Varda Space Industries, the microgravity-enabled life sciences company, raises $187 million in Series C funding to make ...

Venture capital companies remained the most active space investors in recent months, contributing 77% of 2025 funding in the ...

Rocket Lab's high-margin data networks and Neutron's potential $5.6B revenue could drive growth. Click here to read an ...

NASA officials remain eager for Starliner to begin these regular crew rotation flights, even as its sole destination, the ISS ...

Rooted in Varda’s early photography, the Musée Carnavalet’s show illuminates and clarifies the singular nature of a great ...

The SpaceX program is still in the early stages of development and the plans could change. The effort is highly reliant on ...

The funds will be used to improve the company's flight cadence and expand its pharmaceutical lab capabilities.

Varda Space Industries, which is leveraging reusable rockets to manufacture drugs in low Earth orbit, has received more fuel for its endeavors in the form of a $187 million series C fundraising haul.

AST SpaceMobile (ASTS), Planet Labs (PL), and BlackSky (BKSY) have been on a tear lately. Since early April, all four of these names have more than doubled – in just three months – led by a nearly 215 ...

Firefly Aerospace has filed paperwork to go public, part of a trend of space companies taking traditional approaches to ...